| 0 |
BLOOD METHANOL INCREASED |
1 |
0.0500 |
| 1 |
HYPERKALIURIA |
2 |
0.0370 |
| 2 |
OSMOLAR GAP |
2 |
0.0323 |
| 3 |
OSMOLAR GAP INCREASED |
3 |
0.0297 |
| 4 |
DIFFUSE AXONAL INJURY |
2 |
0.0241 |
| 5 |
BLOOD GLUCAGON INCREASED |
1 |
0.0217 |
| 6 |
CEREBRAL CIRCULATORY FAILURE |
1 |
0.0161 |
| 7 |
BLOOD OSMOLARITY INCREASED |
4 |
0.0122 |
| 8 |
HEPATIC ARTERY OCCLUSION |
1 |
0.0118 |
| 9 |
STARVATION KETOACIDOSIS |
2 |
0.0099 |
| 10 |
ANION GAP |
6 |
0.0095 |
| 11 |
RENAL CELL CARCINOMA RECURRENT |
1 |
0.0079 |
| 12 |
PYROGLUTAMIC ACIDOSIS |
2 |
0.0050 |
| 13 |
CEREBROVASCULAR INSUFFICIENCY |
1 |
0.0041 |
| 14 |
HEPATIC ARTERY THROMBOSIS |
1 |
0.0034 |
| 15 |
BASAL GANGLIA INFARCTION |
1 |
0.0029 |
| 16 |
ANALGESIC DRUG LEVEL INCREASED |
4 |
0.0025 |
| 17 |
HYPOXIC ENCEPHALOPATHY |
1 |
0.0024 |
| 18 |
BRAIN HERNIATION |
7 |
0.0023 |
| 19 |
ANION GAP INCREASED |
3 |
0.0022 |
| 20 |
ALCOHOL POISONING |
6 |
0.0022 |
| 21 |
NEUROLOGICAL EXAMINATION ABNORMAL |
1 |
0.0021 |
| 22 |
PO2 INCREASED |
1 |
0.0020 |
| 23 |
CRYSTALLURIA |
1 |
0.0018 |
| 24 |
CRYSTAL URINE PRESENT |
1 |
0.0018 |
| 25 |
BRAIN DEATH |
5 |
0.0016 |
| 26 |
ANOXIC ENCEPHALOPATHY |
1 |
0.0016 |
| 27 |
PRODUCT INEFFECTIVE |
1 |
0.0013 |
| 28 |
BRAIN OEDEMA |
16 |
0.0013 |
| 29 |
VASOPLEGIA SYNDROME |
2 |
0.0012 |
| 30 |
PRODUCT NAME CONFUSION |
1 |
0.0009 |
| 31 |
ACIDOSIS |
7 |
0.0009 |
| 32 |
HEPATOTOXICITY |
17 |
0.0008 |
| 33 |
ACUTE HEPATIC FAILURE |
10 |
0.0007 |
| 34 |
METABOLIC ACIDOSIS |
23 |
0.0007 |
| 35 |
THROMBOPHLEBITIS SUPERFICIAL |
2 |
0.0007 |
| 36 |
COAGULOPATHY |
10 |
0.0006 |
| 37 |
HEPATORENAL SYNDROME |
1 |
0.0006 |
| 38 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
3 |
0.0006 |
| 39 |
PUPIL FIXED |
1 |
0.0006 |
| 40 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
1 |
0.0006 |
| 41 |
SPLENIC INFARCTION |
1 |
0.0006 |
| 42 |
PATIENT DISSATISFACTION WITH TREATMENT |
1 |
0.0005 |
| 43 |
ENCEPHALOPATHY |
12 |
0.0005 |
| 44 |
HAEMODIALYSIS |
4 |
0.0005 |
| 45 |
METHAEMOGLOBINAEMIA |
1 |
0.0004 |
| 46 |
DIABETES INSIPIDUS |
1 |
0.0004 |
| 47 |
DRUG-INDUCED LIVER INJURY |
13 |
0.0004 |
| 48 |
RENAL CELL CARCINOMA |
2 |
0.0004 |
| 49 |
RESPIRATORY DEPRESSION |
5 |
0.0004 |
| 50 |
HYPERAMMONAEMIA |
2 |
0.0004 |
| 51 |
HYPOTHERMIA |
4 |
0.0004 |
| 52 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
1 |
0.0004 |
| 53 |
BLOOD LACTIC ACID INCREASED |
2 |
0.0004 |
| 54 |
TACHYPNOEA |
5 |
0.0004 |
| 55 |
INTESTINAL ISCHAEMIA |
2 |
0.0004 |
| 56 |
INTRACRANIAL PRESSURE INCREASED |
2 |
0.0004 |
| 57 |
LACTIC ACIDOSIS |
11 |
0.0003 |
| 58 |
LIVER INJURY |
8 |
0.0003 |
| 59 |
RESPIRATORY RATE DECREASED |
1 |
0.0003 |
| 60 |
ELECTROENCEPHALOGRAM ABNORMAL |
1 |
0.0003 |
| 61 |
TOXICITY TO VARIOUS AGENTS |
50 |
0.0003 |
| 62 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
16 |
0.0003 |
| 63 |
INTENTIONAL OVERDOSE |
18 |
0.0003 |
| 64 |
CARDIOGENIC SHOCK |
4 |
0.0003 |
| 65 |
VENTRICULAR ARRHYTHMIA |
1 |
0.0003 |
| 66 |
RESPIRATORY ACIDOSIS |
1 |
0.0003 |
| 67 |
MENTAL STATUS CHANGES |
7 |
0.0003 |
| 68 |
POLYURIA |
2 |
0.0002 |
| 69 |
EUGLYCAEMIC DIABETIC KETOACIDOSIS |
1 |
0.0002 |
| 70 |
HYPOGLYCAEMIA |
11 |
0.0002 |
| 71 |
DRUG TOXICITY |
3 |
0.0002 |
| 72 |
SHOCK |
5 |
0.0002 |
| 73 |
SUSPECTED SUICIDE |
1 |
0.0002 |
| 74 |
DISSEMINATED INTRAVASCULAR COAGULATION |
3 |
0.0002 |
| 75 |
SINUS TACHYCARDIA |
3 |
0.0002 |
| 76 |
RENAL TUBULAR NECROSIS |
2 |
0.0002 |
| 77 |
BRAIN INJURY |
2 |
0.0002 |
| 78 |
REBOUND EFFECT |
2 |
0.0002 |
| 79 |
OVERDOSE |
37 |
0.0002 |
| 80 |
COMA |
8 |
0.0002 |
| 81 |
LEUKOCYTOSIS |
3 |
0.0002 |
| 82 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0002 |
| 83 |
ELECTROCARDIOGRAM QT PROLONGED |
5 |
0.0001 |
| 84 |
PRODUCT PRESCRIBING ISSUE |
3 |
0.0001 |
| 85 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 86 |
HAEMODYNAMIC INSTABILITY |
1 |
0.0001 |
| 87 |
HYPERTHERMIA |
1 |
0.0001 |
| 88 |
HAEMOLYSIS |
1 |
0.0001 |
| 89 |
DRUG SCREEN POSITIVE |
1 |
0.0001 |
| 90 |
GENERALISED TONIC-CLONIC SEIZURE |
2 |
0.0001 |
| 91 |
DRUG LEVEL INCREASED |
2 |
0.0001 |
| 92 |
CARDIOTOXICITY |
1 |
0.0001 |
| 93 |
GRAND MAL CONVULSION |
1 |
0.0001 |
| 94 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 95 |
ACUTE KIDNEY INJURY |
16 |
0.0001 |
| 96 |
SEROTONIN SYNDROME |
2 |
0.0001 |
| 97 |
TACHYCARDIA |
9 |
0.0001 |
| 98 |
INCONTINENCE |
1 |
0.0001 |
| 99 |
PANCREATITIS |
5 |
0.0001 |
| 100 |
HYPOTENSION |
18 |
0.0001 |
| 101 |
CEREBRAL HAEMORRHAGE |
3 |
0.0001 |
| 102 |
ILEUS |
1 |
0.0001 |
| 103 |
PNEUMONIA ASPIRATION |
2 |
0.0001 |
| 104 |
HYPOPHAGIA |
2 |
0.0001 |
| 105 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 106 |
RHABDOMYOLYSIS |
3 |
0.0001 |
| 107 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2 |
0.0001 |
| 108 |
HEPATOCELLULAR INJURY |
1 |
0.0001 |
| 109 |
DIALYSIS |
1 |
0.0001 |
| 110 |
INTENTIONAL PRODUCT MISUSE |
6 |
0.0001 |
| 111 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 112 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 113 |
CYANOSIS |
1 |
0.0001 |
| 114 |
DRUG ABUSE |
5 |
0.0001 |
| 115 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 116 |
DELIRIUM |
2 |
0.0001 |
| 117 |
NEUROTOXICITY |
1 |
0.0001 |
| 118 |
BRADYCARDIA |
3 |
0.0001 |
| 119 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 120 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 121 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 122 |
DRUG INEFFECTIVE |
69 |
0.0001 |
| 123 |
HERNIA |
1 |
0.0001 |
| 124 |
CHOKING |
1 |
0.0001 |
| 125 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 126 |
CARDIAC ARREST |
4 |
0.0000 |
| 127 |
RENAL FAILURE ACUTE |
2 |
0.0000 |
| 128 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 129 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 130 |
HAEMATEMESIS |
1 |
0.0000 |
| 131 |
OFF LABEL USE |
33 |
0.0000 |
| 132 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 133 |
ASCITES |
1 |
0.0000 |
| 134 |
RENAL INJURY |
1 |
0.0000 |
| 135 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 136 |
HEPATIC FAILURE |
1 |
0.0000 |
| 137 |
SUICIDE ATTEMPT |
2 |
0.0000 |
| 138 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 139 |
HAEMORRHAGE |
3 |
0.0000 |
| 140 |
HYPERKALAEMIA |
1 |
0.0000 |
| 141 |
HEART RATE DECREASED |
1 |
0.0000 |
| 142 |
PRODUCT USE IN UNAPPROVED INDICATION |
7 |
0.0000 |
| 143 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 144 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 145 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 146 |
DYSARTHRIA |
1 |
0.0000 |
| 147 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 148 |
TREATMENT FAILURE |
2 |
0.0000 |
| 149 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 150 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 151 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 152 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 153 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 154 |
DRUG INTERACTION |
3 |
0.0000 |
| 155 |
MEDICATION ERROR |
1 |
0.0000 |
| 156 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 157 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 158 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 159 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 160 |
AMNESIA |
1 |
0.0000 |
| 161 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 162 |
HYPERTENSION |
3 |
0.0000 |
| 163 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 164 |
AGITATION |
1 |
0.0000 |
| 165 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 166 |
COMPLETED SUICIDE |
1 |
0.0000 |
| 167 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 168 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 169 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 170 |
HEART RATE INCREASED |
1 |
0.0000 |
| 171 |
SOMNOLENCE |
2 |
0.0000 |
| 172 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 173 |
RENAL FAILURE |
1 |
0.0000 |
| 174 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 175 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 176 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 177 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 178 |
PYREXIA |
2 |
0.0000 |
| 179 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 180 |
ASTHENIA |
2 |
0.0000 |
| 181 |
ANAEMIA |
1 |
0.0000 |
| 182 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 183 |
FEELING ABNORMAL |
1 |
0.0000 |
| 184 |
FATIGUE |
2 |
0.0000 |
| 185 |
NAUSEA |
2 |
0.0000 |
| 186 |
DEATH |
2 |
0.0000 |
| 187 |
RASH |
1 |
0.0000 |
| 188 |
MALAISE |
1 |
0.0000 |
| 189 |
VOMITING |
1 |
0.0000 |
| 190 |
DYSPNOEA |
1 |
0.0000 |
| 191 |
PAIN |
1 |
0.0000 |
| 192 |
DIARRHOEA |
1 |
0.0000 |